Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kikuzubam (PBO-326) vs Mabthera in DLBCL
NCT01277172Phase 3Unknown
- Sponsor
- Probiomed
- Start
- Oct 2010
- Primary completion
- Sep 2011
- Countries
- 1
01
Overview
A Phase 3 trial of PBO-326 in diffuse large B-cell lymphoma (DLBCL), sponsored by Probiomed. Status: unknown.
02
Drugs
PBO-326
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01277172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01277172.